Therapeutic effects of transcranial direct current stimulation on loss of motor function caused by experimental mild traumatic brain injury
Öz
Purpose: Traumatic brain injury (TBI) is a serious illness that causes behavioral disorders such as locomotor activity, learning, and memory. This study aims to investigate the behavioral effects of transcranial Direct Current Stimulation (tDCS) treatment on locomotor activity in an experimental traumatic brain injury model and to investigate the levels of IL-1β and IL-18 in the motor cortex tissue.
Materials and Methods: 30 male 3-month-old Wistar albino rats were used. The TBI model was established using the Marmarou method. 2 hours after TBI, sham and TBI+tDCS groups were treated with 0.5 mA 30 minutes anodal tDCS treatment for 2 days. Locomotor activity was evaluated in open field test. IL-1β and IL-18 levels in motor cortex tissue were measured by the ELISA method..
Results: Compared to the sham group, locomotor activity results showed significant decreases in the TBI group while the TBI+tDCS group showed significant increases compared to the TBI group. There were significant increases in IL-1β and IL-18 values in the motor cortex of the animals in the TBI group compared to the sham group, while there was a significant decrease in the TBI+tDCS group compared to the TBI group.
Conclusion: tDCS treatment was shown to have therapeutic effects on neuroinflammation against traumatic brain injury.
Anahtar Kelimeler
Motor Function, Therapeutic Treatment, Traumatic Brain Injury, transcranial Direct Current Stimulation
Destekleyen Kurum
This work was supported by the Coordination Unit of Scientific Research Projects of Erciyes University (Project number: TIP19001.21.003)
Proje Numarası
Project number: TIP19001.21.003
Kaynakça
- Akçay G. Weight drop models in traumatic brain injury. Mid Blac Sea J Health Sci. 2023;9:375-84.
- Capizzi A, Woo J, Verduzco-Gutierrez M. Traumatic brain injury: An overview of epidemiology, pathophysiology, and medical management. Med Clin North Am. 2020;104:213-38.
- Galgano M, Toshkezi G, Qiu X, Russell T, Chin L, Zhao LR. Traumatic brain injury: current treatment strategies and future endeavors. Cell Transplant. 2017;26:1118-30.
- Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7:728-41.
- Yi JH, Hazell AS. Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury. Neurochem Int. 2006;48:394-403.
- Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391-7.
- Yang B, Zhang R, Sa Q, Du Y. Rhamnazin ameliorates traumatic brain injury in mice via reduction in apoptosis, oxidative stress, and inflammation. Neuroimmunomodulation. 2022;29:28-35.
- Rana A, Singh S, Deshmukh R, Kumar A. Pharmacological potential of tocopherol and doxycycline against traumatic brain injury-induced cognitive/motor impairment in rats. Brain Inj. 2020;34:1039-50.
- Wang H, Lynch JR, Song P, et al. Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. Exp Neurol. 2007;206:59-69.
- Benninger DH, Lomarev M, Lopez G, et al. Transcranial direct current stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2010;81:1105-11.
